Tag: PAAG15A
Synspira’s cystic fibrosis treatment PAAG15A gets FDA orphan designation
Synspira has been given the orphan designation status by the US Food and Drug Administration (FDA) for poly (acetyl, arginyl) glucosamine (PAAG15A) for cystic fibrosis ... Read More